An Open-Label Trial of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-1/rhIGFBP-3) in Myotonic Dystrophy Type 1

OBJECTIVE: To evaluate the safety and tolerability of recombinant human insulin-like growth factor-1 (rhIGF-1) complexed with IGF binding protein-3 (rhIGF-1/rhIGFBP-3) in patients with myotonic dystrophy type 1 (DM1). DESIGN: Open-label dose-escalation clinical trial. SETTING: University medical cen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Heatwole, Chad R., Eichinger, Katy J., Friedman, Deborah I., Hilbert, James E., Jackson, Carlayne E., Logigian, Eric L., Martens, William B., McDermott, Michael P., Pandya, Shree K., Quinn, Christine, Smirnow, Alexis M., Thornton, Charles A., Moxley, Richard T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3374954/
https://ncbi.nlm.nih.gov/pubmed/20837825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2010.227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados